AMY REID: Open Payments
NPI 1598004715 · LUTZ, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 16 payments from 10 companies in 2025. Trend: 2023 $549 · 2024 $793 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 1 | $100 |
| Abbott Laboratories | 3 | $84 |
| PFIZER INC. | 3 | $66 |
| ABIOMED | 1 | $41 |
| Boston Scientific Corporation | 2 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| CVRx, Inc. | 1 | $25 |
| Mannkind Corporation | 1 | $21 |
| AtriCure, Inc. | 1 | $21 |
| Nuwellis, Inc. | 1 | $19 |
Products named: FUROSCIX, CARDIOMEMS, VYNDAQEL, Barostim Neo System, THORATEC HEARTMATE 3 LVAS IMPLANT KIT, AFREZZA, ATRICLIP LAA EXCLUSION SYSTEM, FARXIGA.
Industry payments across FL — which companies pay providers there.
